{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:59:07Z","timestamp":1761919147250},"reference-count":24,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1971,10,1]]},"DOI":"10.1136\/jnnp.34.5.502","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T21:02:42Z","timestamp":1226350962000},"page":"502-507","source":"Crossref","is-referenced-by-count":61,"title":["Psychiatric aspects in Parkinsonism treated with L-dopa"],"prefix":"10.1136","volume":"34","author":[{"given":"A. R.","family":"Damasio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lobo-Antunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000467952","article-title":"Psychopharmacodynamie des neuroleptiques. Effets d'organisation sur les syndromes paranoides","volume":"3","author":"Barahona-Fernandes, H.J.","year":"1970","unstructured":"Barahona-Fernandes, H. J. (1970). Psychopharmacodynamie des neuroleptiques. Effets d'organisation sur les syndromes paranoides. Int. Pharmacopsychiat., 3, 94-118.","journal-title":"Int. Pharmacopsychiat"},{"key":"ref_2","first-page":"791","article-title":"L-dopa therapy in Parkinson's disease. A critical review of nine years'","volume":"101","author":"Barbeau, A.","year":"1969","unstructured":"Barbeau, A. (1969). L-dopa therapy in Parkinson's disease. A critical review of nine years' experience. Canad. med. Assoc. J., 101, 791-800.","journal-title":"experience. Canad. med. Assoc. J"},{"key":"ref_3","first-page":"744","article-title":"L-dopa in postencephalitic parkinsonism","volume":"1","author":"Calne, D.B.; Stern, G.M.; Laurence, D.R.; Sharkey, J.; Armitage, P.","year":"1969","unstructured":"Calne, D. B., Stern, G. M., Laurence, D. R., Sharkey, J., and Armitage, P. (1969). L-dopa in postencephalitic parkinsonism. Lancet, 1, 744-747.","journal-title":"Lancet"},{"key":"ref_4","first-page":"973","article-title":"L-dopa in idiopathic parkinsonism","volume":"2","author":"Calne, D.B.; Spiers, A.S.D.; Stern, G.M.Laurence D.R.; Armitage, P.","year":"1969","unstructured":"Calne, D. B., Spiers, A. S. D., Stern, G. M. Laurence D. R., and Armitage, P. (1969a). L-dopa in idiopathic parkinsonism. Lancet, 2, 973-976.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archneur.1970.00480270003001","article-title":"Psychosis and other psychiatric manifestations of levodopa therapy","volume":"23","author":"Celesia, G.G.; Barr, A.N.","year":"1970","unstructured":"Celesia, G. G., and Barr, A. N. (1970). Psychosis and other psychiatric manifestations of levodopa therapy. Arch. Neurol. (Chic.), 23, 193-200.","journal-title":"Arch. Neurol. (Chic.)"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM196902132800701","article-title":"Modification of parkinsonism-chronic treatment with L-dopa","volume":"280","author":"Cotzias, G.C.; Papavasiliou, P.S.; Gellene, R.","year":"1969","unstructured":"Cotzias, G. C., Papavasiliou, P. S., and Gellene, R. (1969). Modification of parkinsonism-chronic treatment with L-dopa. New Engl. J. Med., 280, 337-345.","journal-title":"New Engl. J. Med"},{"key":"ref_7","first-page":"611","article-title":"L-dopa, parkinsonism, and depression","volume":"2","author":"Damisio, A.R.; Lobo Antunes, J.; Macedo, C.","year":"1970","unstructured":"Damisio, A. R., Lobo Antunes, J., and Macedo, C. (1970). L-dopa, parkinsonism, and depression. Lancet, 2, 611-612.","journal-title":"Lancet"},{"issue":"908-91","key":"ref_8","first-page":"1","article-title":"Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients","volume":"1","author":"Goodwin, F.K.; Brodie, H.K.H.; Murphy, D.L.; Bunney, Jr, W.E.","year":"1970","unstructured":"Goodwin, F. K., Brodie, H. K. H., Murphy, D. L., and Bunney, W. E., Jr. (1970). Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients. Lancet, 1, 908-91 1.","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression, and mortality","volume":"17","author":"Hoehn, M.M.; Yahr, M.D.","year":"1967","unstructured":"Hoehn, M. M. and Yahr, M. D. (1967). Parkinsonism: onset, progression, and mortality. Neurology (Minneap.), 17, 427-442.","journal-title":"Neurology (Minneap.)"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0140-6736(70)92535-3","article-title":"Mental symptoms in Parkinsonian patients treated with L-dopa","volume":"2","author":"Jenkins, R.B.; Groh, R.H.","year":"1970","unstructured":"Jenkins, R. B., and Groh, R. H. (1970). Mental symptoms in Parkinsonian patients treated with L-dopa. Lancet, 2, 177-180.","journal-title":"Lancet"},{"key":"ref_11","first-page":"173","article-title":"Desipramine in treatment of Parkinson's disease. A placebo-controlled study","volume-title":"Third Symposium on Parkinson's Disease","author":"Laitinen, L.","year":"1969","unstructured":"Laitinen, L. (1969). Desipramine in treatment of Parkinson's disease. A placebo-controlled study. In Third Symposium on Parkinson's Disease, pp. 173-176. Edited by F. J. Gillingham and I. M. L. Donaldson. Livingstone: Edinburgh."},{"key":"ref_12","first-page":"443","article-title":"Report to the Portuguese","volume":"59","author":"Lobo Antunes, J.; Macedo, C.; Damasio, A.R.","year":"1971","unstructured":"Lobo Antunes, J., Macedo, C., and Damasio, A. R. (1971). Report to the Portuguese Society of Neurology and Psychiatry, October. Medico (Porto), 59, 443-464.","journal-title":"Society of Neurology and Psychiatry"},{"key":"ref_13","first-page":"660","article-title":"L-dopa plus decarboxylase inhibitor in depression","volume":"2","author":"Matussek, N.; Benkert, O.; Schneider, K.; Otten, H.; Pohlmeier, H.","year":"1970","unstructured":"Matussek, N., Benkert, O., Schneider, K., Otten, H., and Pohlmeier, H. (1970). L-dopa plus decarboxylase inhibitor in depression. Lancet, 2, 660-661.","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7326\/0003-4819-72-1-29","article-title":"Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa)","volume":"72","author":"McDowell, F.; Lee, J.E.; Swift, T.; Sweet, R.D.; Ogsbury, J.S.; Kessler, J.T.","year":"1970","unstructured":"McDowell, F., Lee, J. E., Swift, T., Sweet, R. D., Ogsbury, J. S., and Kessler, J. T. (1970). Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa). Ann. int. Med., 72, 29-35.","journal-title":"Ann. int. Med"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00005053-195912000-00004","article-title":"Relation between Parkinsonism and psychiatric disorder","volume":"129","author":"Mettler, F.A.; Crandell, A.","year":"1959","unstructured":"Mettler, F. A., and Crandell, A. (1959). Relation between Parkinsonism and psychiatric disorder. J. nerv. ment. Dis., 129, 551-563.","journal-title":"J. nerv. ment. Dis"},{"key":"ref_16","first-page":"60","article-title":"Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction","volume":"5","author":"Randrup, A.","year":"1970","unstructured":"Randrup, A. (1970). Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction. Mod. Probl. Pharmacopsychiat., 5, 60-65.","journal-title":"Mod. Probl. Pharmacopsychiat"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF00404607","article-title":"Stereotyped activities produced by amphetamine in several animal species and man","volume":"11","author":"Randrup, A.; Munkvad, I.","year":"1967","unstructured":"Randrup, A., and Munkvad, I. (1967). Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia (Berl.), 11, 300-310.","journal-title":"Psychopharmacologia (Berl.)"},{"key":"ref_18","first-page":"321","article-title":"The significance of dopaminereceptor blockade for the action of neuroleptic drugs","volume":"129","author":"Rossum, J.M.","year":"1967","unstructured":"Rossum, J. M. van (1967). The significance of dopaminereceptor blockade for the action of neuroleptic drugs. International Congress Series No. 129. Excerpta Med. (Amst.), 321-329.","journal-title":"International Congress Series"},{"key":"ref_19","first-page":"1231","article-title":"Effects of L-dopa in patients with dementia","volume":"1","year":"1970","unstructured":"Sacks, 0. W., Messeloff, C., Schwartz, W., Goldfarb, A., and Kohl, M. (1970). Effects of L-dopa in patients with dementia. Lancet, 1, 1231.","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000127780","article-title":"Effects of mood, motivation, stress and alertness on the performance in Parkinson's disease","volume":"150","author":"Schwab, R. S.; Zieper, 1","year":"1965","unstructured":"Schwab, R. S., and Zieper, 1. (1965). Effects of mood, motivation, stress and alertness on the performance in Parkinson's disease. Psychiat. Neurol., 150, 345-357.","journal-title":"Psychiat. Neurol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00005053-196209000-00002","article-title":"Cognitive functions in Parkinson's disease","volume":"135","author":"Talland, G.","year":"1962","unstructured":"Talland, G. (1962). Cognitive functions in Parkinson's disease. J. nerv. ment. Dis., 135, 196-205.","journal-title":"J. nerv. ment. Dis"},{"key":"ref_22","volume-title":"Comprehensive Textbook of Psychiatry","author":"Waggoner, R.W.","year":"1967","unstructured":"Waggoner, R. W. (1967). In Comprehensive Textbook of Psychiatry. Edited by A. M. Freedman and H. I. Kaplan. Williams and Wilkins: Baltimore."},{"key":"ref_23","first-page":"257","article-title":"Critical analysis of the disability in Parkinson's disease","volume":"5","author":"Webster, D.D.","year":"1968","unstructured":"Webster, D. D. (1968). Critical analysis of the disability in Parkinson's disease. Mod. Treat., 5, 257-282.","journal-title":"Mod. Treat"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.1969.00480160015001","article-title":"Treatment of Parkinsonism with levodopa","volume":"21","author":"Yahr, M.D.; Duvoisin, R.C.; Schear, M.J.; Barrett, R.E.; Hoehn, M.M.","year":"1969","unstructured":"Yahr, M. D., Duvoisin, R. C., Schear, M. J., Barrett, R. E., and Hoehn, M. M. (1969). Treatment of Parkinsonism with levodopa. Arch. Neurol. (Chic.), 21, 343-354.","journal-title":"Arch. Neurol. (Chic.)"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.34.5.502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:26:27Z","timestamp":1601087187000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.34.5.502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1971,10,1]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1971,10,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.34.5.502","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1971,10,1]]}}}